Staphylococcal enterotoxin B (SEB) is a potent superantigen produced by Staphylococcus aureus that triggers a strong immune response, characterized by cytokine storm, multi-organ failure, and often death. When inhaled, SEB can cause acute lung injury (ALI) and respiratory failure. In this study, we investigated the effect of resveratrol (RES), a phytoallexin, on SEB-driven ALI and mortality in mice. We used a dual-exposure model of SEB in C3H/HeJ mice, which caused 100% mortality within the first 5 days of exposure, and treatment with RES resulted in 100% survival of these mice up to 10 days post-SEB exposure. RES reduced the inflammatory cytokines in the serum and lungs, as well as T cell infiltration into the lungs caused by SEB. Treatment with RES also caused increased production of transforming growth factor-beta (TGF-b) in the blood and lungs. RES altered the miRNA profile in the immune cells isolated from the lungs. Of these, miR-193a was strongly induced by SEB and was down-regulated by RES treatment. Furthermore, transfection studies and pathway analyses revealed that miR-193a targeted several molecules involved in TGF-b signalling (TGFb2, TGFbR3) and activation of apoptotic pathways death receptor-6 (DR6). Together, our studies suggest that RES can effectively neutralize SEB-mediated lung injury and mortality through potential regulation of miRNA that promote anti-inflammatory activities.
trans-endothelial infiltration of immune cells, which causes the release of several cytotoxic and pro-inflammatory mediators, such as interferon-c (IFN-c), interleukin-6 (IL-6), IL-8 and tumour necrosis factor-alpha (TNF-a). 3, 7, 8 The incidence and mortality rate of ALI remain high in the United States, as evidenced by the fact that over 200 000 patients developed the condition annually with 40% of these cases being fatal. 9 SEB is a potent virulence factor produced by Staphylococcus aureus (S. aureus), a Gram-positive bacterium.
Among the enterotoxins produced by S. aureus, SEB is the most well-characterized and researched. Ingested SEB often leads to classic food poisoning symptoms in humans, while respiratory inhalation of SEB has the potential to be life-threatening as it can induce toxic shock syndrome. 10 Due to this, and the fact that SEB is extremely stable and easily aerosolized, the Centers for Disease Control (CDC) has listed this enterotoxin as a select agent, with potential to be used as a biological warfare agent. 11, 12 The lethal nature of SEB is due to the fact that this toxin is a highly potent superantigen, classified as such because of its ability to activate a large proportion of T cells and thereby trigger massive amounts of pro-inflammatory cytokines. 13 SEB, like other superantigens, bypasses normal antigen processing and presentation by binding directly to the major histocompatibility complex-II (MHC-II) of antigen-presenting cells
(APCs). Then, the MHC-II/SEB complex binds nonspecifically to T cells through the T-cell receptor (TCR) and results in activation and
proliferation of a large number of T cells. 14, 15 Inhalation of this virulent factor into the lungs leads to massive activation of infiltrating immune cells, the release of several cytokines (termed a "cytokine storm"), destruction of the lung-barrier architecture allowing increased tissue permeability and ultimately leading to the failure of normal respiratory function. 13, 16, 17 Current treatment options for this condition are limited, often consisting only of supportive care or the use of immunosuppressive drugs with various negative side effects. 1, 18 Therefore, it is essential that better treatment options are explored for ALI patients.
Resveratrol is a natural polyphenolic phytochemical product found in a wide variety of plants and their products such as the skins of red grapes, peanuts and blueberries. 19, 20 The varied bioactivity of this phytochemical has been shown to promote health in a number of ways, including acting as an anti-cancer, anti-ageing and anti-inflammatory agent. 21, 22 In addition to a recent report suggesting resveratrol could be used as an inhalant in dried powder form in the treatment of inflammatory lung diseases, 23 a previous report from our laboratory showed that this compound worked through multiple pathways to protect mice from SEB-induced ALI. 24 In this study, we expand upon our previous findings by testing the efficiency of resveratrol to protect mice from a more robust and lethal SEB-induced ALI in the mouse. In addition, we explored how this natural product modulates microRNA (miR) to initiate changes in SEB-induced cytokine release and immune cell activation. In particular, miR-193a (previous ID: miR-193a-3p, miRbase.org) was found to be significantly up-regulated after exposure to SEB, and this miR targets components involved in TGF-b and apoptotic signalling pathways. Treatment of SEB-exposed mice with RES showed a marked decrease in expression of this miR. These data suggest that RES may protect SEB-mediated toxicity by decreasing the expression of miR- To study the effects of resveratrol on SEB-induced ALI, mice were challenged with SEB with a previously described fatal dual-dose method in C3H/HeJ mice. 25, 26 SEB was intranasally administrated initially at 5 lg (250 lg/Kg BW) diluted in a final volume of 25 lL PBS. During SEB-administration, anesthetized mice were held vertically as SEB droplets were added directly into the nostril opening, waiting for 1-3 minutes until all droplets were inhaled. The second dose of SEB was given intraperitoneally in a dose of 2 lg (100 lg/ Kg BW) diluted in 100 lL of sterile PBS. RES was given orally at two-time-periods at a dose of 100 mg/Kg. The initial resveratrol oral administration through gavage was given 24 hours (Day-1) prior to SEB exposure, and the second administration was given 90 minutes (Day 0) before the second challenge with SEB. Mice were watched for any distress, and moribund mice were immediately euthanized.
| Blood collection and tissue harvesting
Blood was collected from the retro-orbital vein of isofluraneanesthetized animals for serological and haematological investigations. For cytokine analysis, blood was collected at two-time-points: 3 and 48 hours post-second SEB-dose exposure. Serum was separated from collected blood by centrifugation and stored at À80°C 
| Bronchoalveolar lavage fluid (BALF) collection
BALF was collected as previously described. 16, 24, 27 Briefly, euthanized animals were perfused, and the trachea was tied with surgical silk (Ethicon, USA) at the upper region before removing the lungs from the body. One mL of sterile PBS was injected into the trachea (3-4 times) to flush out BALF from the lungs. Collected BALF was centrifuged to separate the infiltrated cells from the supernatant, which was stored at À80°C until further analysis.
| Pulmonary function tests (PFT) and vascular leak measurement
To evaluate the degree of SEB-induced dysfunction of the respiratory system, Buxco whole-body plethysmograph (Buxco, Troy, NY, USA) was used to compare respiratory system parameters, such as airway resistance, among the study groups as previously described. 16 Briefly, each mouse was held in a whole-body plethysmograph chamber which delivered varying concentrations (6.25, 12.5, 25 and 50 mg/mL) of methacholine (Biomedical, France), an airway constrictor which creates an acute asthma-like state. Vascular leak and tissue permeability were measured as previously described. 17 Evans blue dye (Sigma-Aldrich, USA) (1%) was injected (100 lL) intravenously 2 hours prior to sacrificing experimental mice, and then the lung lobes were excised and stored in formamide (Fisher Scientific, USA) for 48 hours at 37°C.
| Histopathological evaluation
Harvested lungs were fixed in 4% paraformaldehyde (Sigma-Aldrich, USA) overnight before being embedded into paraffin and obtaining 5-lm sections for haematoxylin and eosin (H&E) staining. H&E slides were imaged and analysed with Cytation-5 microscope (Biotek, USA) and Metamorph Software (Molecular Devices, USA). were determined with online miRNA database (www.microrna.org).
| miR validation and target gene quantification by PCR
To validate the miR observations from the microarray and quantitate genes of interest, complementary DNA (cDNA) was prepared from isolated RNA with miScript II RT kit (Qiagen, USA), and qRT-PCR (Bio-Rad, USA) was used to determine expression levels. To validate miR, mousespecific miRNA primers were purchased from Qiagen, and PCR reactions were performed using miScript II primer assay (Qiagen, USA). The 
| Transfection experiments with miR-193a mimic and inhibitor
Transfection of SEB-activated splenocytes cultures with miR-193a mimic and inhibitor was performed as previously described. 29 Briefly, splenocytes were cultured in 24-well plates ( 2 9 
| Statistical analysis
Graphpad prism 6.0 software was used for statistical analysis, and built-in one-way ANOVA (Tukey's multiple comparisons tests) and multiple t test comparisons with Holm-Sidak correction method were applied. Each experimental group was composed of 4-5 mice. P < .05 was considered to be statistically significant.
3 | RESULTS
| Resveratrol attenuates clinical parameters
after exposure to "dual dose" of SEB
We first determined whether RES would protect mice in the dualdose model of SEB exposure, which leads to almost 100% mortality as shown by us previously. 27 As shown in Figure 1A , 100% of mice exposed to SEB + VEH died within the 5-day period. Also, such mice started showing signs of weakness by 24 hours. Interestingly, 100% of the mice that were given treatment with RES survived for more than 10 days after SEB exposure, and there were no visible clinical signs in mice that survived. To study vascular leak in the lungs following SEB exposure, we injected Evans blue dye intravenously (i.v.) as described 17 animals. 24 It is for this reason, we did not include this group. However, we did include this vehicle or resveratrol alone for histopathological studies of the lungs, which showed no significant changes when compared to na€ ıve animals ( Figure 1C ).
| Resveratrol alters cytokine levels brought on
by "cytokine storm" after exposure to SEB
To investigate the effect of RES on the cytokine storm induced by SEB, we studied the levels of cytokines in the serum at 3 ( Pulmonary function tests depicting specific airway resistance (sRaw). Significance was measured in panel D only as following: √ = P < .01, √√ = P < .0001 in comparison between Na€ ıve and SEB + VEH or SEB + RES groups. a = P < .05, b = P < .01, v = P < .001 in comparison between SEB + VEH and SEB + RES groups in panel D. Significance in panels A and B was depicted as follows: *P < .05, **P < .01 F I G U R E 2 Resveratrol (RES) decreases cellular infiltration in the lungs of SEBtreated mice. Mice were exposed to SEB and treated with RES as described in Figure 1 legend. (A) Total number of mononuclear cells isolated from the lungs. (B) Total number of T cell subsets analysed after antibody staining and flow cytometry analysis. Significance was depicted as follows: *P < .05, **P < .01, ***P < .001
group when compared to naive mice, and treatment with RES was able to significantly reduce all inflammatory cytokines except IFN-c and IL-6 ( Figure 5 ). Interestingly, in the BALF, we noted a marked increase in TGF-b levels in SEB + VEH mice when compared to na€ ıve mice, and SEB + RES groups showed an additional increase in this cytokine.
F I G U R E 3
Effect of RES on serum cytokines induced by SEB. Mice were treated with SEB and RES as described in Figure 1 legend. Serum was collected from all experimental groups (Na€ ıve, SEB + VEH, SEB + RES) 3 h after second dose of SEB. ELISA kits were used to detect (A) TNFa,
(B) IL-2, (C) MCP-1, (D) IFN-c, (E) IL-6 and (F) TGF-b.
Significance was depicted as follows: *P < .05, **P < .01, ***P < .001, ****P < .0001
Effect of RES on SEB-induced serum cytokine levels at 48 h. Serum was collected from all experimental groups (Na€ ıve, SEB + VEH, SEB + RES) 48 h after second dose of SEB. ELISA kits were used to detect (A) TNFa,
Significance was depicted as follows: *P < .05, **P < .01, ***P < .001, ****P < .0001 ALGHETAA ET AL. 
| miR-193a is down-regulated in RES-treated mice exposed to SEB, and it targets genes DR6, TGFb2 and TGFbR3
Next, we studied the miR-target alignment miRSVR and PhastCons scores (microrna.org) for miR-193a and the potential target proteins, TGFb2, TGFbR3 and DR6. The scores shown in Figure 7A indicated that miR-193a had a high probability of targeting these proteins, although the scores for DR6 were somewhat weaker compared to TFGb2 and TGFbR3 ( Figure 7A ). Next, we validated the expression of miR-193a with qRT-PCR. As shown in Figure 7B , miR-193a expression was significantly higher in cells from SEB + VEH group when compared to na€ ıve controls, and it was reduced by half in the SEB + RES group, confirming the observations from the array results that RES was down-regulating miR-193a expression. As many of these targets were linked to TGFb and we observed alterations in TGF-b in the SEB + RES-treated group, we determined expression of this cytokine in the mononuclear cells isolated from the lungs.
The data showed that cells from the SEB + RES group had signifi- Significance was depicted as follows: *P < .05, **P < .01, ***P < .001, ****P < .0001
inhibitor, thereby validating the in silico data obtained ( Figure 7H -J, respectively). Protein expression of TGFb2, TGFbR3 and DR6 was higher in cells that were transfected with inhibitor when compared to transfected cells with mimic and normalized to mock ( Figure 7K ).
Taken together, these experiments showed that miR-193a-3p levels are altered by RES under SEB-activated conditions, and this, in turn, could lead to an up-regulation of normally targeted proteins TGFb2, TGFbR3 and DR6, which are involved in important processes, such as TGF-b and NF-jB signalling.
| DISCUSSION
SEB, produced by Gram-positive bacteria S. aureus, is a superantigen because of its ability to activate a large proportion of T cells. 10 Such activation leads to cytokine storm and consequently considerable damage to internal tissues. 13 Thus, SEB poses a significant threat, which is why the CDC has classified it as category B select agent with the potential of being used as a biological weapon. 11, 12 Exposure to SEB in humans can lead to food poisoning as well as fatal toxic shock. Inhalation of SEB can cause significant damage to the lungs resulting in respiratory failure. 16, 17 In the current study, performed with the 100% lethal dual-exposure model to SEB, we demonstrate that treatment with RES can completely rescue the mice from mortality. Our data suggest that this may result from the potent suppression of inflammation mediated by RES.
Resveratrol has been used as a therapeutic agent for thousands of years and has been a staple in Eastern medicine, known as ko-jokon, to treat aliments of the heart, liver, blood vessels and various other organs. 30 This compound is a well-known ligand for the AhR, and AhR activation has been shown to promote anti-inflammatory Treg differentiation while suppressing pro-inflammatory Th17 cells. 31 In the current study, we demonstrate that RES can act as a potent anti-inflammatory agent in combating the negative effects such as cytokine storm associated with inhalation of SEB, which can result in a fatal ALI condition. This study reinforces our previous results highlighting RES use in a much more acute and severe model of SEBinduced ALI. 24 Our data demonstrate that RES was able to decrease several SEB-mediated inflammatory cytokines in the lungs and blood, thereby preventing lung injury.
Resveratrol has been shown to be effective against a variety of different types of inflammatory lung disorders. [32] [33] [34] [35] [36] In many of these studies, RES was found to dampen the production of inflammatory cytokines and modulate a number of factors involved in inflammatory signalling pathways, such as toll-like receptor 4 (TLR4), myeloid differentiation primary response gene 88 (myd88) and nuclear factor-kappa B (NF-jB). 37 Interestingly, a recent study showed that a RES-curcumin hybrid mix was able to decrease production levels of TNF-a, IL-6 and IL-12 in the lung caused by LPS. 32 Despite clear indication that RES is a potent immunosuppressant in lung inflammatory and injury models, the precise mechanisms of action of RES remain unclear. It is for that reason that we investigated the role of miRNA in the lung injury model. Significance was depicted as follows: *P < .05, **P < .01, ***P < .001, ****P < .0001 inflammatory response. 43 SEB itself was shown by our laboratory to significantly alter miRs to promote ALI through induction of miR-155 to suppress SOCS1, a negative regulatory of cytokine signalling. 44 In the current study, we found miR-193a to be up-regulated upon exposure to SEB but was significantly down-regulated after treatment with RES. Interestingly, current literature shows miR-193a to be involved in both anti-inflammatory and pro-inflammatory properties. For example, miR-193a was reduced in intestinal inflammation in colitis; 45 however, our own laboratory showed that this miR may target inflammatory IL-12 in a study on patients with post-traumatic stress disorder (PTSD). 46 This is possible because any given miR may regulate many processes by targeting different molecules. In that context, it is interesting to note that in the current study, we identified that miR-193a may target TGF-b pathway.
In the current study, we noted that at 3 hours post-SEB exposure, while inflammatory cytokines in the blood were highly induced, TGF-b levels were very low. However, at 48 hours, the TGF-b levels increased compared to 3 hours, while RES caused an additional increase in its levels. We also noted that RES caused marked increase in TGF-b levels in the BALF as well. TGF-b is known to act as a potent anti-inflammatory agent, and one of the mechanisms of immunosuppression could include its ability to induce Tregs. 47 In addition, we found that miR-193a targets components of the TGF-b signalling pathway, mainly TGFb2 and TGFbR3. Thus, by down-regulating miR-193a, RES up-regulates these targets. TGF-b has three homologues (TGFb1, TGFb2 and TGFb3) in the mammalian system, and it has been suggested that these variants could have differing effects on signalling pathways. In our study, we showed that miR-193a directly targeted TGFb2, which has been shown to attenuate the production of LPS-induced inflammatory cytokines IL-6, IL-1b and TNF-a by ERK activation. 47 Interestingly, TGFbR3, one of the three receptor subunits for TGF-b, has been shown to play an important and necessary role in TGFb2 signal transduction. 48 In this regard, RES through down-regulation of miR-193a could be playing dual roles in anti-inflammatory TGF-b signalling. Butz et al found that the relationship between TGF-b and miRNAs biogenesis is an autoregulatory feedback loop, as many miRNAs may target a single gene, a single miRNA can target multiple genes. 49 Also, in a study of lung cancer, the researcher found there is a negative regulatory model between the expression of miR-193 and TGF-b-induced lung cancer. 50 Down-regulation of this miR could lead to increased production of TGFb2, and its signal transduction could be further enhanced by the presence of increased TGFbR3. This combination may, in turn, lead to decreased cytokine production induced by SEB.
Another identified and validated target for miR-193a in our studies was DR6 (also known as TNFRSF21), which is involved in apoptosis and activation of NF-jB. 51, 52 In CD4 + T cells, knock-down of DR6 leads to hyper proliferation in response to both TCR-mediated and protein-antigen stimulation. 53 Therefore, to control or negatively regulate T cell proliferation, DR6 should be present. In connection to our findings, miR-193a is up-regulated in the presence of SEB; thus, targeted DR6 would be down-regulated. This could help explain how T cells are able to proliferate and survive after being exposed to SEB.
However, upon treatment with RES, this effect is reversed, leading to decreased miR-193a and increased DR6, thereby halting T cell proliferation. These data are consistent with our observation that RES treatment in SEB-exposed mice caused significant a decrease in T cell numbers in the lungs.
Taken together, the current study demonstrates that RES can successfully attenuate SEB-mediated inflammatory processes, acute lung injury and mortality in mice, thereby demonstrating that it is a highly potent anti-inflammatory agent. This is especially important as SEB-inhalation by humans can produce lethal toxic shock, yet there is little to no treatment options other than standard supportive care.
We also identify a potential and novel mechanism to explore, and that is the modulation of miRs, specifically miR-193a, which has not received much attention yet as a molecule involved in blocking inflammation when compared to other more well-known miRs. As highlighted in this work, this miR could be involved in the regulation of TGF-b pathways, a key modulator of inflammation. miR-193a-3p
could also be a very promising potential therapeutic target not only in SEB-mediated diseases but also in other inflammatory diseases where TGF-b is often implicated.
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